CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Return 73.3%
This Quarter Return
+43.14%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$1.36B
AUM Growth
-$236M
Cap. Flow
-$54.8M
Cap. Flow %
-4.02%
Top 10 Hldgs %
69.81%
Holding
40
New
4
Increased
10
Reduced
8
Closed
9

Top Buys

1
PCVX icon
Vaxcyte
PCVX
$57.7M
2
NUVL icon
Nuvalent
NUVL
$53.4M
3
SRRK icon
Scholar Rock
SRRK
$41.1M
4
NRIX icon
Nurix Therapeutics
NRIX
$25.4M
5
CRDF icon
Cardiff Oncology
CRDF
$23.4M

Top Sells

1
CLDX icon
Celldex Therapeutics
CLDX
$55M
2
CATX icon
Perspective Therapeutics
CATX
$44.7M
3
KURA icon
Kura Oncology
KURA
$35.2M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
$34.1M
5
ARVN icon
Arvinas
ARVN
$29.6M

Sector Composition

1 Healthcare 99.44%
2 Financials 0.56%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBOT
26
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$798M
$5.25M 0.38%
500,000
– –
CELC icon
27
Celcuity
CELC
$2.31B
$5.24M 0.38%
400,000
-1,122,332
-74% -$14.7M
VTGN icon
28
VistaGen Therapeutics
VTGN
$111M
$4.65M 0.34%
1,575,000
– –
AVTX icon
29
Avalo Therapeutics
AVTX
$134M
$3.59M 0.26%
483,000
– –
THRD
30
DELISTED
Third Harmonic Bio
THRD
$2.45M 0.18%
237,704
-1,122,865
-83% -$11.6M
NKTX icon
31
Nkarta
NKTX
$151M
$876K 0.06%
351,848
-4,310,225
-92% -$10.7M
ARVN icon
32
Arvinas
ARVN
$559M
– –
-1,200,000
Closed -$29.6M
CABA icon
33
Cabaletta Bio
CABA
$141M
– –
-1,100,000
Closed -$5.19M
CATX icon
34
Perspective Therapeutics
CATX
$263M
– –
-3,350,000
Closed -$44.7M
CCCC icon
35
C4 Therapeutics
CCCC
$190M
– –
-3,410,384
Closed -$19.4M
CLDX icon
36
Celldex Therapeutics
CLDX
$1.51B
– –
-1,618,937
Closed -$55M
KURA icon
37
Kura Oncology
KURA
$706M
– –
-1,800,000
Closed -$35.2M
RYTM icon
38
Rhythm Pharmaceuticals
RYTM
$6.95B
– –
-650,000
Closed -$34.1M
SNDX icon
39
Syndax Pharmaceuticals
SNDX
$1.39B
– –
-885,000
Closed -$17M
TIL icon
40
Instil Bio
TIL
$205M
– –
-150,929
Closed -$10.2M
1
2